For condition: Atopic Dermatitis
Clinical Trials for Adults with Atopic Dermatitis (Eczema)
Study Summary
Who can participate?
Adults 18 years of age or older with a moderate-to-severe Atopic Dermatitis (AD) – Eczema are needed for this clinical trial.
Inclusion Criteria:
- Have a physician-confirmed chronic AD for at least 6 months prior to study screening.
- Have AD lesions covering 10%* or more of body surface area (BSA)
- Previously had inadequate response to treatment with topical medications or documented reason why topical treatments are considered medically inappropriate.
* 1% of your body surface area is roughly equal to the palm of your hand (no wrists or fingers)
What are the benefits?
As a participation in our research trial, you will receive an investigational treatment (active study drug) or placebo via injection at no cost. All study-related assessments will also be provided at no charge. In addition, you may also be eligible for reimbursement of study-related expenses.
How long will the study last?
- 76 weeks and involves 11 visits to the study centre.
For more information about this trial, please visit ClinicalTrials.gov
